Advanced Search
  • Dec 3, 2012
    System Designed to Improve Glucose Control in Critical Care Patients

    MINNEAPOLIS - December 3, 2012 - Medtronic, Inc. (NYSE:MDT) today announced CE (Conformité Européenne) Mark approval of its innovative Sentrino® Continuous Glucose Management System, the first...

  • Nov 26, 2012

    MINNEAPOLIS - Nov 26, 2012 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Piper Jaffray Healthcare Conference on...

  • Nov 20, 2012
    Revenue of $4.1 Billion Grew 5% on a Constant Currency Basis; 2% as Reported

    MINNEAPOLIS - November 20, 2012 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2013, which ended October 26, 2012. The Company reported...

  • Nov 13, 2012
    New Indication Expands Labeled Uses for Valiant® Captivia® System in U.S.; Six-Month Results of RESCUE Trial Will Be Presented at VEITHsymposium

    MINNEAPOLIS -- Nov. 13, 2012 -- Consistent with its commitment to clinical excellence, Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has approved the...

  • Nov 13, 2012

    MINNEAPOLIS - Nov. 13, 2012 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2013 on Tuesday, November 20, 2012. A news...

  • Nov 13, 2012

    MINNEAPOLIS - November 13, 2012 - The Federal Circuit Court of Appeals has affirmed the April 2010 jury verdict from the Federal District Court of Delaware that the CoreValve® System infringed a...

  • Nov 6, 2012
    Medtronic Biventricular Pacing Reduces Risk of Death and Heart Failure Visits by 27 Percent, Demonstrating Superiority and Real-World Clinical Benefits Compared to Right Ventricular Pacing

    MINNEAPOLIS and LOS ANGELES - Nov. 6, 2012 - Medtronic, Inc. (NYSE: MDT) today announced interim findings from the BLOCK HF trial, which show that biventricular (BiV) pacing may offer a...

  • Nov 5, 2012

    MINNEAPOLIS - Nov. 5 - 2012 - Medtronic, Inc. (NYSE: MDT) announced today a grant of $250,000 from the Medtronic Foundation to the American Red Cross to support relief efforts in areas affected by...

  • Nov 1, 2012
    Accelerates Globalization and Company's Overall Position in Global Orthopedics Market

    MINNEAPOLIS, Nov. 1, 2012 - Medtronic, Inc. (NYSE: MDT) announced today that it has completed its acquisition of China Kanghui Holdings (NYSE: KH), a leading provider of orthopedic devices in...

  • Oct 29, 2012
    Data Demonstrate High Procedural Success in Late-Breaking Trials Session at the European Association for Cardio-Thoracic Surgery Annual Meeting

    MINNEAPOLIS - October 29, 2012 - Medtronic, Inc. (NYSE: MDT) today announced promising data from the EngagerTM European Pivotal Trial for the investigational Medtronic EngagerTM Transcatheter...